Document is current
Any future updates will be listed below
-
Authors
Kitabatake, Masahiro
Nishioka, Tatsuki
Hara, Atsushi
Yasuike, Kaito
Nakanishi, Yumiko
Miyauchi, Eiji
Ouji-Sageshima, Noriko
Ohno, Hiroshi
Ito, Toshihiro https://orcid.org/0000-0003-1728-2449
-
Funding
Funding for this research was provided by:
Smoking Research Foundation
Japan Agency for Medical Research and Development (JP22zf0127007)
Japan Society for the Promotion of Science (22H00452)
- License Information
-
More Information
Article History
Received: 10 January 2026
Accepted: 16 July 2026
First Online: 31 July 2026
Declarations
Conflict of interest: H.O. reports lecture fees from Miyarisan Pharmaceutical Co., Taisho Pharmaceutical Co., and Tsumura & Co.; expert testimony fees from Ono Pharma Foundation for Oncology, Immunology, and Neurology.
Ethical approval: The animal experimental protocols were approved by the Ethics Review Committee for Animal Experimentation of Nara Medical University (approval number: 12232), and all procedures were carried out according to the Policy on the Care and Use of Laboratory Animals, Nara Medical University.
